Tian Qiu1, Yuxin Shi1, and Weibo Chen2
1Shanghai Public Health Clinical Center Affiliated to Fudan University, Shanghai, China, 2Philips Healthcare,Shanghai,China, Shanghai, China
Synopsis
Liver biopsy is an invasive inspection method of staging liver fibrosis,but we study was to evaluate a new procedure by injecting a Gd-EOB-DTPA that hepatobiliary specific contrast to stage the liver fibrosis non-invasively.
Objective
To
explore and discuss the quantitative evaluation of T1 mapping imaging Gd-EOB-DTPA
enhanced magnetic resonance imaging on liver fibrosis induced by hepatitis B
virus infection.Methods
A
total of 150 patients with chronic hepatitis B were prospectively collected from
August 2016 to August 2018. According to liver biopsy, these patients were
divided into S1 (N=38), S2 (N=30), S3 (N=33), and S4 (N=49) groups. All the
patients were examined with enhanced magnetic resonance imaging of Gd-EOB-DTPA.The
T1 mapping images at 5, 10, 15 and 20 minutes after enhancement were obtained
by Look-Locker method. The T1 relaxation time (T1), the decreased rate of T1
relaxation time (ΔT1%) and ΔR1% were measured. Univariate analysis of variance
(ANOVA) was used to compare between the groups. ROC was used to evaluate the
efficacy of T1、ΔT1% and ΔR1%
in differentiating S1 and S2+S3+S4, S1+S2 and S3+S4,S1+S2+S3 and S4.Results
T1,
ΔT1% and ΔR1% of each group showed statistical significance in the same degree
of fibrosis group, where T1 was decreased gradually, ΔT1% and ΔR1% were increased
gradually with the extension of scanning time, and at different scanning time
points. Except for T1 relaxation time of plain scan, there was no significant
difference between T1, ΔT1% and ΔR1% in the same degree of fibrosis group,
while in the same degree of fibrosis group,ΔT1% and ΔR1% were increased
gradually. The T1 relaxation time was increased with increase in fibrosis
stage, and ΔT1% and ΔR1% were decreased with increased fibrosis stage. There
was statistical difference between S4 and other groups in T1, ΔR1%, S3 and
other groups at each scanning time of ΔT1%, S1 and
other groups of ΔR1%, S1 and S2 were only enhanced at each
scan time. There was statistical difference in ΔT1% after 20 minutes. Identification
of S1 and S2+S3+S4, the scanning time T1 evaluation area under the ROC of liver
fibrosis were 0.646, 0.830, 0.827, 0.831, 0.844, ΔT1% area under ROC were 0.888,
0.889, 0.893, 0.905, ΔR1% area under ROC were 0.866, 0.854, 0.856, 0.869, and
the three indexes in the enhanced scanning time evaluation of liver fibrosis,
S1 and S2+S3+S4 area under the ROC showed no statistical difference. Identification
of S1+S2 and S3+S4, the scanning time T1 evaluation area under the ROC of liver
fibrosis were 0.653,0.831,0.821,0.824,0.832,ΔT1% area under ROC were 0.903,0.893,0.898,0.907,ΔR1%
area under ROC were 0.871,0.850,0.852,0.862,and the three indexes in the
enhanced scanning time evaluation of liver fibrosis, S1+S2 and S3+S4 area under
ROC showed no statistical difference.Identification of S1+S2+S3 and S4, the
scanning time T1 evaluation area under the ROC of liver fibrosis were 0.581,
0.849, 0.837, 0.842, 0.853, ΔT1% area under ROC were
0.888, 0.878, 0.884, 0.897, ΔR1% area under ROC were 0.873, 0.856, 0.861,
0.873, and the three indexes in the enhanced scanning time evaluation of liver
fibrosis, S1+S2+S3 and S4 area under ROC showed no statistical difference.Discussion
Gd-EOB-DTPA
is a hepatocyte specific contrast agent that shortens the T1 relaxation time.
About 50% of Gd-EOB-DTPA can transport organic anion transport polypeptides OATP1B1
and OATP1B3 into normal hepatocytes through organic anion transport peptides on
the liver cell membrane(1), but the extracellular space is still accumulated a
part(2). The T1 relaxation time and its related parameters before and after
enhancement not only reflected the uptake of contrast agent by hepatocytes, but
also reflected the volume of extracellular space. Hepatic fibrosis resulted in decreased
expression of OATP1B1 on the liver cell membrane, thereby reducing the uptake(3).
The more fibrous tissue is deposited in the extracellular space, the more it
enters the liver in a unit time. The smaller the cell mass is, the smaller is the
T1 effect, showing gradually increased T1 with increased stage. In identifying
fibrosis in each group, the area under the ROC with ΔT1% scan time was nearly
90%, sensitivity, specificity and accuracy were more than 80%, showing good
evaluation value. There was no significant difference in the evaluation of
hepatic fibrosis between different scanning time points after enhancement. It
may be due to that the liver function of the patients with hepatic fibrosis is
light, the deposition of fibrosis is not significant, and the liver cells have
strong compensatory function. Conclusion
T1
mapping with Gd-EOB-DTPA enhanced magnetic resonance imaging demonstrated good
evaluation effect on liver fibrosis caused by HBV infection and is expected to
shorten the scanning time of liver fibrosis patients.Acknowledgements
No acknowledgement found.References
[1] Van Beers BE, Pastor CM, Hussain HK.
Primovist, Eovist: what to expect. J Hepatol. 2012. 57(2): 421-9.
[2] Goodwin MD, Dobson JE, Sirlin CB, Lim BG,
Stella DL. Diagnostic challenges and pitfalls in MR imaging with
hepatocyte-specific contrast agents. Radiographics. 2011. 31(6): 1547-1568.
[3] Tsuda N, Harada K, Matsui O. Effect of change
in transporter expression on gadolinium-ethoxybenzyl-diethylenetriamine
pentaacetic acid-enhanced magnetic resonance imaging during
hepatocarcinogenesis in rats[J]. J Gastroenterol Hepatol, 2011, 26(3): 568-576.
DOI:10.1111/j.1440-1746.2010.06494.x.